ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors & Media

  • Home
  • Investors & Media
  • News / Events
  • Press Releases
Investors & Media

Investors & Media

  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • Events
    • Email Alerts
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference

September 3, 2014

ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.

September 2, 2014

ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option

August 27, 2014

ContraFect Corporation Announces Closing of Initial Public Offering

August 4, 2014

ContraFect Announces Pricing of Its Initial Public Offering

July 29, 2014

Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research

May 13, 2014

ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors

April 24, 2014

ContraFect Announces Management Team Changes

November 21, 2013

ContraFect Corporation to Present at 12th Annual BIO Investor Forum

October 1, 2013

ContraFect to Present at the 2013 Stifel Healthcare Conference

September 5, 2013

RSS
  • « Previous
  • 1...
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next »
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter